116 related articles for article (PubMed ID: 23274623)
1. Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2).
Tillib SV; Ivanova TI; Vasilev LA; Rutovskaya MV; Saakyan SA; Gribova IY; Tutykhina IL; Sedova ES; Lysenko AA; Shmarov MM; Logunov DY; Naroditsky BS; Gintsburg AL
Antiviral Res; 2013 Mar; 97(3):245-54. PubMed ID: 23274623
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
Tutykhina IL; Sedova ES; Gribova IY; Ivanova TI; Vasilev LA; Rutovskaya MV; Lysenko AA; Shmarov MM; Logunov DY; Naroditsky BS; Tillib SV; Gintsburg AL
Antiviral Res; 2013 Mar; 97(3):318-28. PubMed ID: 23274786
[TBL] [Abstract][Full Text] [Related]
3. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
4. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
5. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
Front Immunol; 2019; 10():2920. PubMed ID: 31921179
[TBL] [Abstract][Full Text] [Related]
6. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
Musthaq SK; Kumar SR; Szyporta M; Kwang J
Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region.
Smirnov YA; Lipatov AS; Gitelman AK; Claas EC; Osterhaus AD
Arch Virol; 2000; 145(8):1733-41. PubMed ID: 11003481
[TBL] [Abstract][Full Text] [Related]
9. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
[TBL] [Abstract][Full Text] [Related]
10. Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A type.
Hifumi E; Fujimoto N; Ishida K; Kawawaki H; Uda T
J Biosci Bioeng; 2010 Jun; 109(6):598-608. PubMed ID: 20471600
[TBL] [Abstract][Full Text] [Related]
11. Biotinylated Single-Domain Antibody-Based Blocking ELISA for Detection of Antibodies Against Swine Influenza Virus.
Du T; Zhu G; Wu X; Fang J; Zhou EM
Int J Nanomedicine; 2019; 14():9337-9349. PubMed ID: 31819435
[TBL] [Abstract][Full Text] [Related]
12. [Effect of amino acid substitutions in small subunit of avian H5N2 influenza virus hemagglutinin on selection of the mutants resistant to neutralizing monoclonal antibodies].
Ignatieva AV; Timofeeva TA; Rudneva IA; Shilov AA; Masalova OV; Klimova RR; Kushch AA; Ilyushina NA; Kaverin NV
Mol Biol (Mosk); 2015; 49(2):342-50. PubMed ID: 26065262
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
Smolonogina TA; Desheva IuA; Rekstin AR; Mironov AN; Rudenko LG
Vopr Virusol; 2013; 58(6):31-5. PubMed ID: 24772644
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection.
Voronina DV; Shcheblyakov DV; Favorskaya IA; Esmagambetov IB; Dzharullaeva AS; Tukhvatulin AI; Zubkova OV; Popova O; Kan VY; Bandelyuk AS; Shmarov MM; Logunov DY; Naroditskiy BS; Gintsburg AL
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366583
[TBL] [Abstract][Full Text] [Related]
15. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
16. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.
Rudneva IA; Kushch AA; Masalova OV; Timofeeva TA; Klimova RR; Shilov AA; Ignatieva AV; Krylov PS; Kaverin NV
Viral Immunol; 2010 Apr; 23(2):181-7. PubMed ID: 20373998
[TBL] [Abstract][Full Text] [Related]
17. [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
Boravleva EIu; Lomakina NF; Kropotkina EA; Rudneva IA; Iamnikova SS; Rudenko LG; Drygin VV; Gambarian AS
Vopr Virusol; 2011; 56(6):9-14. PubMed ID: 22359942
[TBL] [Abstract][Full Text] [Related]
18. Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus.
He F; Kumar SR; Syed Khader SM; Tan Y; Prabakaran M; Kwang J
Antiviral Res; 2013 Oct; 100(1):207-14. PubMed ID: 23954322
[TBL] [Abstract][Full Text] [Related]
19. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of a natural reassortant H5N2 avian influenza virus in mice.
Li Q; Wang X; Zhong L; Wang X; Sun Z; Gao Z; Cui Z; Zhu J; Gu M; Liu X; Liu X
Vet Microbiol; 2014 Aug; 172(3-4):568-74. PubMed ID: 25037995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
